Breast cancer is a significant health concern worldwide, affecting millions of women each year. In recent times, advancements in medical science have brought about new treatments that offer hope and improved outcomes for patients. One such treatment making waves is Kisqali. What is Kisqali? Kisqali is a medication specifically designed to treat a certain type of breast cancer known as hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer. This type of cancer is one of the most common forms of breast cancer, where cancer cells grow in response to hormones like estrogen. How Does Kisqali Work? Kisqali belongs to a class of drugs called CDK4/6 inhibitors. These drugs work by targeting and blocking certain proteins (CDK4 and CDK6) that help cancer cells grow. By inhibiting these proteins, Kisqali helps to slow down or stop the growth of cancer cells, thereby slowing the progression of the disease. Who Can Benefit from Kisqali? Kisqali is typ...